Long-Term Follow Up of VOY-101 Non-nAMD Extension Study

Enrolling by invitation

Conditions studied: Age-Related Macular Degeneration (AMD), Non-Neovascular Age-Related Macular Degeneration

In brief

Long-Term Follow Up Extension for participants previously enrolled in a VOY-101 study for Advanced Non-Neovascular Age-Related Macular Degeneration

Key facts

Study ID

NCT07660640

Run by

Perceive Biotherapeutics, Inc.

People needed

88

Starts

2026-03-03

Expected to finish

2031-08-30

Last updated by the study team

2026-06-22

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have received an injection of VOY-101 and exited either the PBI-AMD-001 or PBI-AMD-002 Phase 1/2a study of VOY-101.
• Are willing and able to understand and provide informed consent.

You may not qualify if…

• There are no exclusion criteria for this study

Where it is running

• Ophthalmic Consultants of Boston — Boston, Massachusetts, United States
• Retina Consultants of Texas — Bellaire, Texas, United States
• University of Utah — Salt Lake City, Utah, United States
• Sourasky Medical Center - Ichilov — Tel Aviv, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.